Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8232754 | 0.85 | — | — | |
| SCHEMBL24425932 | 0.85 | — | — | |
| SCHEMBL24571704 | 0.80 | CA1 (0.42) | CA1CA2CA4 | |
| SCHEMBL4365281 | 0.80 | TRPA1 (0.38) | CA1CA2CA4 | |
| SCHEMBL3453446 | 0.79 | — | — | |
| SCHEMBL2782632 | 0.73 | THRB (0.32) | CA1CA2CA4 | |
| SCHEMBL1987866 | 0.73 | CA1 (0.35) | CA1CA2CA4 | |
| SCHEMBL21432873 | 0.73 | CA1 (0.31) | CA1CA2CA4 | |
| SCHEMBL24592494 | 0.72 | CA1 (0.38) | CA1CA2CA4 | |
| SCHEMBL25758304 | 0.72 | TRPA1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293519-A1 | INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS | PLIANT THERAPEUTICS INC (US) | 2023-09-21 | — | — | US | disclosed |
| EP-3724251-A1 | IONIC HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | Covestro Intellectual Property GmbH & Co. KG (DE) | 2020-10-21 | — | — | EP | disclosed |
| CN-110396173-A | Ionic hydrophilic polyisocyanates and free radical scavenger and/or peroxide decomposer | COVESTRO DEUTSCHLAND AG | 2019-11-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293519-A1 | INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS | ITGB6, ITGA5, ITGAV | CA1 4644/4885CA2 3868/4885CA4 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.